| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |